Cubist Pharmaceuticals Inc : Cubist Pharmaceuticals to Announce Q112 Financial Results on Wednesday, April 18th, 2012
04/02/2012| 10:45am US/Eastern
Recommend:
Earnings Conference Call & Webcast at 5:00 pm ET
Cubist Pharmaceuticals, Inc. (NASDAQ: CBST) will issue its first quarter
2012 financial results at 4:00 p.m. ET on Wednesday, April 18th,
2012. In connection with this announcement, Cubist will host a
conference call and live audio webcast (with slides) at 5:00 p.m. ET
that same day to discuss its first quarter financial results, business
activities, and financial outlook.
As always, the quarterly earnings call will be available via phone and
webcast. The conference call dial-in information is listed below. To
access the webcast, please log on to the Cubist website at www.cubist.com
at least 15 minutes prior to the start of the call to ensure adequate
time for any software downloads that may be required.
A replay of the webcast and teleconference will be available on Cubist's
website beginning approximately three hours after the call.
******************CONFERENCE CALL & WEBCAST INFORMATION******************
Cubist will host a conference call and live audio webcast to discuss its
first quarter financial results, business activities and financial
outlook.
WHEN: Wednesday, April 18, 2012 at 5:00 p.m. ET
LIVE DOMESTIC &
CANADA CALL-IN: 877-407-8289
LIVE INTERNATIONAL CALL-IN:
201-689-8341
24-HOUR REPLAY DOMESTIC & CANADA: 877-660-6853
24-HOUR REPLAY
INTERNATIONAL: 201-612-7415
REPLAY PASSCODES (BOTH REQUIRED FOR PLAYBACK):
ACCOUNT #: 351
CONFERENCE ID #: 391065
CALL WILL ALSO BE BROADCAST LIVE, LISTEN ONLY, VIA THE WEB AT: www.cubist.com
Replay will be available for 30 days via the Internet at www.cubist.com
*********************************************************************************
About Cubist
Cubist Pharmaceuticals, Inc. is a biopharmaceutical company focused on
the research, development, and commercialization of pharmaceutical
products that address significant unmet medical needs in the acute care
environment. Cubist is headquartered in Lexington, Mass. Additional
information can be found at Cubist's website at www.cubist.com.
INVESTORS:
Cubist Pharmaceuticals, Inc.
Eileen
C. McIntyre, 781-860-8533
Senior Director, Investor Relations
eileen.mcintyre@cubist.com
or
MEDIA:
Cubist
Pharmaceuticals, Inc.
Francis McLoughlin, 781-860-8777
Director,
Corporate Communications
Francis.mcloughlin@cubist.com
© Business Wire 2012
Recommend :
